A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. Chakraborty S, Morganti C, Zaldana K, Rivera Pena B, et al. Leukemia 2026 Feb 17. doi: 10.1038/s41375-026-02883.

Read + Share

Amedeo Smart

Independent Medical Education

Chakraborty S, Morganti C, Zaldana K, Rivera Pena B, et al. A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. Leukemia 2026 Feb 17. doi: 10.1038/s41375-026-02883.
PMID: 41703028